Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01UHA
|
|||
Former ID |
DIB012100
|
|||
Drug Name |
MIS-416
|
|||
Synonyms |
Microparticle adjuvant (anthrax), Virionyx; Microparticle adjuvant (iv, autoimmune disease/cancer/anthrax), Innate Therapeutics
Click to Show/Hide
|
|||
Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 2 | [1] | |
Bacillus anthracis infection [ICD-11: 1G40] | Investigative | [1] | ||
Company |
Innate Therapeutics Ltd
|
References | Top | |||
---|---|---|---|---|
REF 1 | Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis. PLoS ONE 9(1): e87712. January 31, 2014. | |||
REF 2 | DOI: 10.1371/journal.pone.0087712 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.